- Apr 6, 2022
- 8 min
A Pawsitively Innovative Approach to Cancer with Kubanda Cryotherapy
- Mar 24, 2022
- 7 min
Resisting Antibiotic Resistance with Astek Diagnostics
- Mar 9, 2022
- 5 min
Molecular Minute: February 2022
- Mar 2, 2022
- 6 min
Reading Recs: Imagine What Could Be
- Feb 23, 2022
- 7 min
Shedding Senescent Cells with Deciduous Therapeutics
- Feb 16, 2022
- 10 min
Three Drug Ideas that Deserve Redemption
- Feb 9, 2022
- 11 min
Good Ideas Gone Bad: The (Old & New) Worst Drug Launch in History
- Feb 4, 2022
- 5 min
Molecular Minute: January 2022
- Feb 2, 2022
- 9 min
Our Favorite Pharmaceutical Brands of 2021
- Jan 26, 2022
- 10 min
Three Types of Successful Startup Leaders
- Jan 19, 2022
- 10 min
The Race Continues: A One-Year COVID-19 Retrospective
- Jan 12, 2022
- 15 min
Whitepaper: Five Steps to Avoid Startup Fraud
- Dec 8, 2021
- 7 min
Finding Fantastic Founder Fit
- Nov 20, 2021
- 4 min
(Bonus) We'd Approve Almost Any Drug (But We Won't Approve That)
- Nov 17, 2021
- 8 min
The FDA Could Approve Almost Any Drug (But It Won't Approve That)
- Nov 10, 2021
- 7 min
Something Old, Something New: What is a 505(b)2?
- Nov 3, 2021
- 6 min
Driving STEM Education with BioBus
- Oct 27, 2021
- 7 min
Diagnosing Ovarian Cancer, the Silent Killer, with HYPERmelt
- Oct 20, 2021
- 2 min
Pop Quiz - Pharmaceutical Brand or Pokémon Name?
- Oct 6, 2021
- 6 min
Merck Makes Moves with M&A and Molnupiravir Marvels